Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Recombinant Human Erythropoietin Alfa Injection bulk supplier for pharma manufacturers

Recombinant Human Erythropoietin Alfa Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU

Reference Brands: Epogen, Procrit(US), Eprex(EU)

Category: Nephrology

Recombinant Human Erythropoietin Alfa Injection is used to treat anemia in CKD and cancer patients. Marketed as Epogen®, Procrit® (US) and Eprex® (EU), it boosts red blood cell production and reduces transfusion needs in nephrology and oncology care.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Recombinant Human Erythropoietin Alfa Injection is a biologic therapy used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, and HIV treatment. It stimulates red blood cell production, reducing the need for blood transfusions. Commonly marketed as Epogen® and Procrit® in the US, and Eprex® in the EU, Erythropoietin Alfa is a vital medication in nephrology and oncology care. Available in prefilled syringes and vials, it comes in strengths ranging from 2,000 IU to 10,000 IU. Collaborate with WHO-GMP/EU-GMP certified manufacturers to supply high-quality erythropoietin injections for global Pharma B2B markets.

Recombinant Human Erythropoietin Alfa Injection — third party manufacturing & bulk supply

Recombinant Human Erythropoietin Alfa Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Recombinant Human Erythropoietin Alfa Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Recombinant Human Erythropoietin Alfa Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Recombinant Human Erythropoietin Alfa In... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Recombinant Human Erythropoietin Alfa Injection is listed as Injection in 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Recombinant Human Erythropoietin Alfa Injection is referenced against Epogen, Procrit(US), Eprex(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Recombinant Human Erythropoietin Alfa Injection is catalogued under Nephrology on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Atrasentan Hydrochloride

Strength:
0.75 mg, 1.25 mg, 10 mg

Form: Tablets

Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)

View Details
Tiopronin

Strength:
100 mg, 200 mg , 300 mg

Form: Tablets, Capsules

Reference Brands: Thiola (USA), Mercaptamine (EU)

View Details
Nedosiran

Strength:
80 mg, 160 mg

Form: Injection

Reference Brands: Ryplazim (USA)

View Details
Probenecid

Strength:
500 mg

Form: Tablets

Reference Brands: Benemid (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.